Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial (Q64108800)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 May 2019

Language	Label	Description	Also known as
English	Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial	scientific article published on 14 May 2019

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

phase III clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Narikazu Boku

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Yasuhide Yamada

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Junki Mizusawa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Satoru Iwasa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Shigenori Kadowaki

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Norisuke Nakayama

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Mizutomo Azuma

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Takeshi Sakamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Kohei Shitara

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Takao Tamura

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Keisho Chin

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Hiroaki Hata

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Mikihito Nakamori

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Hiroki Hara

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Hirofumi Yasui

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Hiroshi Katayama

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Haruhiko Fukuda

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Takaki Yoshikawa

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Mitsuru Sasako

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Masanori Terashima

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

language of work or name

0 references

publication date

14 May 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

The lancet. Gastroenterology & hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Impact of endoscopic screening on mortality reduction from gastric cancer

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Japanese gastric cancer treatment guidelines 2014 (ver. 4).

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Discrete sequential boundaries for clinical trials

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the world

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601).

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016/S2468-1253(19)30083-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2468-1253(19)30083-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31101534 AND SRC:MED&resulttype=core&format=json

27 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64108800&oldid=2122602417"